NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders
This is a contract result notice, not an open opportunity. Details from the official award data.
This is a large award for Medical Equipment & Pharmaceuticals — above three-quarters of comparable contracts. Based on 9,456 valued Medical Equipment & Pharmaceuticals tenders in our corpus.
The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England, Wales, Scotland and Northern Ireland.
The framework may also be used by private sector contractors and agents working on behalf of the above.
Please refer to Document 05d in the ITO documents for the list of Participating Authorities.
What this notice demands of you
1 named, none in explicit obligation language. Each one is quoted from the notice.
NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders
Matched against the notice text, so this is a floor — the tender pack will demand things the notice never mentions. “Says must” means the quoted sentence itself used obligation language; anything ambiguous is left as a mention.
Make the case to bid
Reveal who to approach at COMMERCIAL MEDICINES UNIT, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
- OCID
- 718f0aba-b827-4ca9-b532-1218b65ff78c
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- CM/PHS/14/5434
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
COMMERCIAL MEDICINES UNIT’s tender network